AdvisorShares Investments LLC Sells 694,836 Shares of InMed Pharmaceuticals Inc. (NASDAQ:INM)

AdvisorShares Investments LLC reduced its holdings in InMed Pharmaceuticals Inc. (NASDAQ:INM) by 94.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 38,460 shares of the company’s stock after selling 694,836 shares during the period. AdvisorShares Investments LLC owned approximately 0.05% of InMed Pharmaceuticals worth $177,000 as of its most recent SEC filing.

InMed Pharmaceuticals Stock Performance

INM opened at $2.99 on Wednesday. The stock has a market cap of $3.60 million, a PE ratio of -0.22 and a beta of 0.30. InMed Pharmaceuticals Inc. has a 1 year low of $1.72 and a 1 year high of $15.70. The stock’s 50 day simple moving average is $2.66 and its 200-day simple moving average is $3.87. The company has a current ratio of 3.05, a quick ratio of 2.44 and a debt-to-equity ratio of 0.09.

InMed Pharmaceuticals (NASDAQ:INM) last announced its quarterly earnings data on Wednesday, February 12th. The company reported ($3.64) earnings per share (EPS) for the quarter. InMed Pharmaceuticals had a negative net margin of 163.75% and a negative return on equity of 90.74%.

About InMed Pharmaceuticals

InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.